Bristol-Myers Squibb Co.’s Yervoy

Bristol-Myers Squibb Co.’s Yervoy

Drugs approved in 2011 included New York-based Bristol’s Yervoy, the first drug cleared to prolong the lives of people with advanced skin cancer that uses patients’ immune systems to attack tumors. Photo: Robert Bruschini/Bristol Myers Squib